Researchers at Stanford University and the Arc Institute designed 16 active viruses using the AI model Evo, which were able to infect bacteria in the laboratory. This achievement, published in the journal Science, represents a new step in biodesign aided by artificial intelligence.

The AI model Evo, trained on extensive genomic data, has the ability to produce new biological sequences. In this study, researchers used this model to design the genomes of bacteriophages and then synthesized and tested the produced sequences in the laboratory.

Out of hundreds of sequences designed by Evo, 16 sequences resulted in the production of active viruses capable of infecting host bacteria and replicating within them. This success demonstrates the capability of artificial intelligence to create complex and functional biological structures.

According to the researchers, this method could pave the way for the development of phage therapy, treatment of antibiotic-resistant infections, and even a better understanding of virus evolution. Additionally, this technique enables the design of specific viruses for industrial and biological applications.

This research shows that artificial intelligence is no longer limited to data analysis but can also serve as a creative tool in biotechnology. However, researchers emphasize the importance of responsible use of this technology and examining its security implications.

This study is considered a significant step in the field of synthetic biology, and its applications are expected to expand in the future. The collaboration between Stanford University and the Arc Institute highlights the role of leading scientific centers in developing innovative tools to address biological challenges.